Invention Grant
- Patent Title: Phage therapy of
-
Application No.: US17038442Application Date: 2020-09-30
-
Publication No.: US11957724B2Publication Date: 2024-04-16
- Inventor: Flavie Pouillot , Hélène Blois
- Applicant: ERYTECH PHARMA
- Applicant Address: FR Lyons
- Assignee: ERYTECH PHARMA
- Current Assignee: ERYTECH PHARMA
- Current Assignee Address: FR Lyons
- Agency: SALIWANCHIK, LLOYD & EISENSCHENK
- Priority: EP 305041 2014.01.10
- Main IPC: A61K35/76
- IPC: A61K35/76 ; A01N63/40 ; C07K14/005 ; C12N7/00 ; C12Q1/18 ; G01N33/569
Abstract:
The present invention relates to bacteriophage therapy. More particularly, the present invention relates to novel bacteriophages having a high specificity against Escherichia coli strains, their manufacture, components thereof, compositions comprising the same and the uses thereof in phage therapy.
Public/Granted literature
- US20210060100A1 PHAGE THERAPY OF E COLI INFECTIONS Public/Granted day:2021-03-04
Information query
